1. Home
  2. ROIV vs CVLT Comparison

ROIV vs CVLT Comparison

Compare ROIV & CVLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$41.76

Market Cap

25.1B

Sector

Health Care

ML Signal

HOLD

Logo Commvault Systems Inc.

CVLT

Commvault Systems Inc.

N/A

Current Price

$131.28

Market Cap

5.6B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
ROIV
CVLT
Founded
2014
1996
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
25.1B
5.6B
IPO Year
2021
2006

Fundamental Metrics

Financial Performance
Metric
ROIV
CVLT
Price
$41.76
$131.28
Analyst Decision
Strong Buy
Buy
Analyst Count
9
18
Target Price
$28.94
$139.53
AVG Volume (30 Days)
7.6M
401.9K
Earning Date
05-28-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.50
Revenue
$8,260,000.00
$1,183,690,000.00
Revenue This Year
N/A
$13.29
Revenue Next Year
$744.61
$13.20
P/E Ratio
N/A
$266.72
Revenue Growth
N/A
18.89
52 Week Low
$13.82
$71.75
52 Week High
$42.50
$198.18

Technical Indicators

Market Signals
Indicator
ROIV
CVLT
Relative Strength Index (RSI) 73.22 45.20
Support Level $27.15 $115.33
Resistance Level N/A $152.63
Average True Range (ATR) 1.35 4.64
MACD 0.45 -0.40
Stochastic Oscillator 92.67 31.81

Price Performance

Historical Comparison
ROIV
CVLT

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About CVLT Commvault Systems Inc.

CommVault Systems Inc provides cyber resiliency solutions designed to help the enterprise protect, secure, and recover its data, applications, and identity systems in a world of increasing cyber threats and attacks. Its offerings provide cyber resilience, including data protection, cyber recovery, data security, and governance, aiming to enable customers to continue business. The company delivers its solutions through Commvault Cloud, a cloud native platform that unifies data security, cyber recovery and identity resilience across on-premises, hybrid, multi-cloud, and software-as-a-service environments. It sells its offerings through subscription-based arrangements, including SaaS and term-based subscriptions, and also offers perpetual licenses, customer support, and professional services.

Share on Social Networks: